BCN HEALTH publishes a study evaluating the incidence, mortality and medical costs associa... 04/10/2023 Healthcare BCN HEALTH conducted a retrospective study based on the records of patients diagnosed with a melanoma and treated in... Partners - BCN Health
ORYZON receives two grants to further explore the role of epigenetic targets in the treatm... 03/10/2023 Healthcare Two collaborative projects with public research centers with a global budget of 2.3 million euros. Partners - Oryzon Genomics
#BIOSPAIN2023Interview | We discover the first collaborative project between Alexion and A... 21/09/2023 Healthcare BioSpain A space whose primary goal is to become one of the largest private centers of excellence in clinical development and... AseBio - AstraZeneca
#BIOSPAIN2023Interview | "Epigenetic therapies can complement existing cancer treatments" 14/09/2023 Healthcare BioSpain We analyze the role of epigenetics in cancer research with Douglas Faller, Chief Medical Officer of Oryzon, Gold Sponsor... AseBio - Oryzon Genomics
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys 07/09/2023 Healthcare Innovative drugs The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based... Partners - Asabys Partners
#BIOSPAIN2023Interview | "It is good news that the CNMV has laid the foundations to measu... 07/09/2023 Healthcare BioSpain We spoke with Clara Campàs, director and co-founder of Asabys, Gold Sponsor of BIOSPAIN 2023, to learn all the details... AseBio - Asabys Partners
The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park 24/08/2023 Healthcare Innovative drugs Advanced therapies The company specialises in the development of molecules for oncological and gastrointestinal immunological treatments... Partners - Parc Científic de Barcelona
Barcelona Science Park companies break record after raising €142M in 2022 23/08/2023 Healthcare Access to innovation Financing 2022 has been a historic year in economic and innovation indicators for the ecosystem of companies that form part of the... Partners - Parc Científic de Barcelona
#BIOSPAIN2023Interview | "The evolution of the approach to treating skin diseases in recen... 25/08/2023 Healthcare We spoke with Volker Koscielny, Chief Medical Officer of Almirall, Platinum Sponsor of BIOSPAIN 2023, to understand the... AseBio - Almirall
VIVEbiotech participates in the European MAGIC project 11/07/2023 Healthcare Personalized medicine Advanced therapies Gene editing International EU projects Financing VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is... Partners - VIVEbiotech
